Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 480 participants.
Also called NCT05028140
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 480 participants
- Sponsor
- EMS
- Registry
-
NCT05028140
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Brazil
- Registry status
- Recruiting
Technical summary
Registry record NCT05028140. Randomized; double masking; primary purpose treatment. Start 2024-10-08 (actual); primary completion 2026-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus
- Acronym
- PIEMONTE
- Condition
- Type II Diabetes
- Intervention (Drug)
- PIEMONTE
- Intervention (Other)
- PIEMONTE PLACEBO
- Intervention (Drug)
- EMPAGLIFLOZIN
- Intervention (Other)
- PLACEBO EMPAGLIFLOZIN
- Intervention (Drug)
- PIOGLITAZONE
- Intervention (Other)
- PLACEBO PIOGLITAZONE
- Lead sponsor
- EMS
Record details
- Record id
cardio:ct-nct05028140- Content hash
3614d4dd347de734abdaf8662d5a90e9f76d9a8cef2810a1271727ecd1e61b6c